Opportunity
Simpler Grants.gov #PAR-23-286
NCI Pathway to Independence Award (K99/R00) for Early-Stage Postdoctoral Researchers
Buyer
National Institutes of Health
Posted
November 08, 2023
Respond By
October 14, 2026
Identifier
PAR-23-286
NAICS
541715
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is offering the Pathway to Independence Award (K99/R00) to support early-stage postdoctoral researchers: - Supports transition from postdoctoral training to independent, tenure-track or equivalent faculty positions - Focuses on research in cancer control, cancer prevention, and cancer data sciences - Research must not involve leading an independent clinical trial, but participation in mentor-led trials is allowed - No specific Original Equipment Manufacturers (OEMs) or vendors are involved, as this is a research grant - Funding instrument is a discretionary grant; no cost sharing or matching required - Eligible applicants include government, nonprofit, business, and educational entities, as well as certain tribal and regional organizations - Foreign institutions are not eligible, but foreign components within U.S. organizations are permitted
Description
The NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program aims to support postdoctoral fellows with research and/or clinical doctoral degrees in transitioning to independent tenure-track or equivalent faculty positions. The program provides independent NCI research support to help awardees launch competitive, independent research careers, particularly encouraging research in cancer control, prevention, and data sciences. This funding opportunity is specifically for candidates proposing research without leading an independent clinical trial, though research in clinical trials led by a mentor is permitted. The award facilitates a timely transition from mentored postdoctoral research to independent investigator status.